С槼ºÖ±²¥

Object moved to here.

Blood Testing for Phosphatidylethanol | Hepatobiliary Disease | С槼ºÖ±²¥ | С槼ºÖ±²¥ Network

С槼ºÖ±²¥

[Skip to Navigation]
Sign In
JAMADiagnostic Test Interpretation
May 15, 2024

Blood Testing for Phosphatidylethanol

Author Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois
С槼ºÖ±²¥. 2024;331(23):2039-2040. doi:10.1001/jama.2024.3607

Case

A 36-year-old man presented for evaluation of elevated liver enzymes 2 months after undergoing a liver transplant for acute-on-chronic liver failure due to alcohol-associated hepatitis. He had metabolic comorbidities including obesity (body mass index of 30.6) and dyslipidemia. After the liver transplant, there was no evidence of organ rejection or biliary complications. He was asymptomatic and reported last alcohol use was prior to liver transplant. Vital signs were normal and physical examination revealed a well-healed abdominal surgical scar. Serum alcohol level was undetectable and urine drug screening results were positive for cannabinoids. Liver ultrasonography findings were normal. Liver biopsy showed 50% to 60% macrovesicular steatosis (normal <5%), mild portal inflammation, scattered apoptotic bodies, and hepatocyte ballooning (Table 1).

Table 1.  Patient’s Diagnostic Testing Results
Box Section Ref ID

How do you interpret these test results?

  1. Acute rejection of the transplanted liver.

  2. Alcohol-associated liver disease.

  3. Drug-induced liver injury.

  4. Metabolic dysfunction–associated steatotic liver disease.

Discussion

Answer

B. Alcohol-associated liver disease.

Test Characteristics

Phosphatidylethanol (PEth) is a whole blood marker of alcohol that can be detectable for up to 4 weeks after alcohol consumption. PEth is not a single molecule. It is a group of phospholipid homologues with a phosphoethanol head and 2 carboxylic acid side chains that attach to the erythrocyte surface in the presence of blood ethanol, catalyzed by the enzyme phospholipase D.1 PEth species are categorized by the number of carbon atoms (typically 14-22) and double bonds; the 16:0/18:1 and 16:0/18:2 homologues are the most common forms.1 Testing for PEth can be performed using dried blood spots or whole blood collected in ethylenediamine tetra-acetic acid tubes.

PEth is a direct biomarker of alcohol that forms after ethanol consumption. A study of 16 recently abstinent volunteers who consumed alcohol to achieve a blood alcohol concentration of 1 g/kg (single ingestion of 110-230 mL of 40% vodka) demonstrated that PEth was detectable within 1 hour of alcohol consumption, peaked at 8 hours, and was detectable for 3 to 12 days after consumption, with a mean half-life of 3 days.2 A PEth concentration less than 20 ng/mL indicates minimal or no recent alcohol consumption and a PEth concentration greater than 200 ng/mL correlates with heavy alcohol consumption (≥4 standard drinks daily). A standard drink is defined as equivalent to 12 fl oz of beer, 5 fl oz of wine, or 1.5 fl oz of distilled spirits.3

PEth formation and degradation are not affected by age, sex, or organ dysfunction such as chronic kidney disease or hepatic dysfunction.1 The rate of PEth formation depends on the level and activity of phospholipase D, which varies among individuals. The degradation rate of PEth also varies, with an estimated mean half-life of 4 to 10 days. PEth may be detectable up to 5 weeks after heavy alcohol consumption.1 Blood PEth level increases with higher quantity and frequency of alcohol consumption and decreases with time elapsed since last ingestion of alcohol.

A false-positive PEth test result may occur if an individual receives a blood transfusion from a person who recently consumed alcohol, due to PEth on donated erythrocytes.4 Falsely low PEth concentrations may occur in patients with low haptoglobin levels, consistent with intravascular hemolysis.5 PEth has a sensitivity of 94.5% to 99% and a specificity of 100% for high levels of alcohol consumption (≥4 standard drinks daily) and a sensitivity of 81.8% for lower levels of alcohol ingestion.6 In 2024, Medicare reimbursement was $114.43 for PEth testing.7

Application of Test Result to This Patient

The patient’s PEth concentration of 137 ng/dL was consistent with recent alcohol ingestion despite his undetectable serum alcohol level and initial report of no recent alcohol consumption.

What Are Alternative Diagnostic Testing Approaches?

Blood, breath, and urine alcohol levels detect alcohol consumed in the preceding 12 to 24 hours. Ethyl glucuronide and ethyl sulfate are formed by enzymatic conjugation of ethanol with glucuronic acid and sulfate, respectively, and may be detected in urine within 2 to 3 hours of alcohol consumption and remain detectable for 4 to 5 days after consumption.8 False-positive urinary ethyl glucuronide and ethyl sulfate test results may occur due to kidney dysfunction or bacterial fermentation in the urine (eg, cystitis); false-negative results may occur with use of diuretics or intentional dilution of urine specimens.1 Ethyl glucuronide can be detected in hair and nails for approximately 2 months after alcohol cessation in frequent drinkers9 (Table 2).7,10 Direct alcohol biomarkers (PEth and ethyl glucuronide) have been studied and validated in patients with and without liver disease.

Table 2.  Diagnostic Accuracy of Biomarkers for Alcohol in Patients With Liver Disease

Patient Outcome

Additional testing revealed a urine ethyl sulfate level of 45 475 ng/mL (reference, <100 ng/mL) and urine ethyl glucuronide level of >10 000 ng/mL (reference, <500 ng/mL). The patient disclosed consuming 5 shots of vodka daily for 7 days prior to presentation. He was prescribed naltrexone and referred to an intensive outpatient program for alcohol use disorder. Liver chemistries were normal 2 weeks after presentation and PEth was undetectable 3 weeks later. In the clinic 2 months later, he reported alcohol abstinence; was meeting with his psychotherapy, psychiatry, and social work teams; and had undetectable blood PEth levels and normal liver graft function.

Box Section Ref ID

Clinical Bottom Line

  • Phosphatidylethanol consists of a group of phospholipids formed on the surface of erythrocytes in the presence of ethanol in the blood.

  • Phosphatidylethanol is a direct alcohol biomarker with concentrations affected by the quantity and frequency of alcohol consumption and duration since the last drink of alcohol.

  • Phosphatidylethanol may be detectable in the blood for 4 to 5 weeks after heavy alcohol consumption.

Back to top
Article Information

Corresponding Author: Amanda Cheung, MD, 676 N St Clair St, Ste 1900, Chicago, IL 60611 (amanda.cheung@nm.org).

Published Online: May 15, 2024. doi:10.1001/jama.2024.3607

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank the patient for granting permission to publish this information.

Section Editor: Kristin Walter, MD, Deputy Editor.
References
1.
Viel  G, Boscolo-Berto  R, Cecchetto  G, Fais  P, Nalesso  A, Ferrara  SD.  Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.   Int J Mol Sci. 2012;13(11):14788-14812. doi:
2.
Schröck  A, Thierauf-Emberger  A, Schürch  S, Weinmann  W.  Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol—a drinking study with 16 volunteers.   Int J Legal Med. 2017;131(1):153-160. doi:
3.
Ulwelling  W, Smith  K.  The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines.   J Forensic Sci. 2018;63(6):1634-1640. doi:
4.
Snozek  CLH, Kinard  TN, Alegria  KN, Jannetto  PJ, Langman  LJ.  Artificial elevation of phosphatidylethanol due to red blood cell transfusion.   Clin Biochem. 2023;120:110651. doi:
5.
Årving  A, Hilberg  T, Sovershaev  M, Bogstrand  ST, Høiseth  G.  Falsely low phosphatidylethanol may be associated with biomarkers of haemolytic disease.   Basic Clin Pharmacol Toxicol. 2023;132(2):223-230. doi:
6.
Hahn  JA, Fatch  R, Barnett  NP, Marcus  GM.  Phosphatidylethanol vs transdermal alcohol monitoring for detecting alcohol consumption among adults.   С槼ºÖ±²¥ Netw Open. 2023;6(9):e2333182. doi:
7.
Centers for Medicare & Medicaid Services. Clinical Laboratory Fee Schedule. Accessed February 8, 2024.
8.
Nanau  RM, Neuman  MG. Ìýµþ¾±´Ç³¾´Ç±ô±ð³¦³Ü±ô±ð²õ and biomarkers used in diagnosis of alcohol drinking and in monitoring therapeutic interventions.  Ìýµþ¾±´Ç³¾´Ç±ô±ð³¦³Ü±ô±ð²õ. 2015;5(3):1339-1385. doi:
9.
Fosen  JT, Morini  L, Sempio  C,  et al.  Ethyl glucuronide elimination kinetics in fingernails and comparison to levels in hair.   Alcohol Alcohol. 2017;52(5):580-586. doi:
10.
Arnts  J, Vanlerberghe  BTK, Roozen  S,  et al.  Diagnostic accuracy of biomarkers of alcohol use in patients with liver disease: a systematic review.   Alcohol Clin Exp Res. 2021;45(1):25-37. doi:
×